Xeris Pharmaceuticals | XERS - Ebit

Stock Price
7.12
Daily Change
-0.22 -3.00%
Monthly
0.42%
Yearly
94.01%
Q1 Forecast
7.13

Xeris Pharmaceuticals reported $7.89M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Celltrion KRW 301.04B 58.57B Sep/2025
Cspc Pharmaceutical CNY 1.22B 60.54M Sep/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Divis Laboratories Ltd INR 7.75B 1.58B Sep/2025
Eli Lilly USD 7.41B 391.2M Sep/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Malin Corporation EUR -1.1M 300K Dec/2024
Medical Developments International AUD -12.12M 3.97M Jun/2023
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Organigram Holdings CAD -28.05M 25.94M Sep/2025
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Pharma Mar EUR -3.96M 28.11M Sep/2025
Qiagen NV USD 141.06M 6.64M Sep/2025
Sartorius EUR 150.1M 11.7M Sep/2025
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Supernus Pharmaceuticals USD -60.18M 72.33M Sep/2025
Tilray USD -20.01M 9.34M Sep/2025
Zz Pientze Pharmaceu CNY 501.33M 15.6M Sep/2025